102 related articles for article (PubMed ID: 27695006)
1. Discovery of Isoquinolinoquinazolinones as a Novel Class of Potent PPARγ Antagonists with Anti-adipogenic Effects.
Jin Y; Han Y; Khadka DB; Zhao C; Lee KY; Cho WJ
Sci Rep; 2016 Oct; 6():34661. PubMed ID: 27695006
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside F2 possesses anti-obesity activity via binding with PPARγ and inhibiting adipocyte differentiation in the 3T3-L1 cell line.
Siraj FM; SathishKumar N; Kim YJ; Kim SY; Yang DC
J Enzyme Inhib Med Chem; 2015 Feb; 30(1):9-14. PubMed ID: 24666293
[TBL] [Abstract][Full Text] [Related]
3. Bisphenol S- and bisphenol A-induced adipogenesis of murine preadipocytes occurs through direct peroxisome proliferator-activated receptor gamma activation.
Ahmed S; Atlas E
Int J Obes (Lond); 2016 Oct; 40(10):1566-1573. PubMed ID: 27273607
[TBL] [Abstract][Full Text] [Related]
4. CBMG, a novel derivative of mansonone G suppresses adipocyte differentiation via suppression of PPARγ activity.
Kim HK; Hairani R; Jeong H; Jeong MG; Chavasiri W; Hwang ES
Chem Biol Interact; 2017 Aug; 273():160-170. PubMed ID: 28625492
[TBL] [Abstract][Full Text] [Related]
5. 20(S)-hydroxycholesterol inhibits PPARgamma expression and adipogenic differentiation of bone marrow stromal cells through a hedgehog-dependent mechanism.
Kim WK; Meliton V; Amantea CM; Hahn TJ; Parhami F
J Bone Miner Res; 2007 Nov; 22(11):1711-9. PubMed ID: 17638575
[TBL] [Abstract][Full Text] [Related]
6. Pimozide, a novel fatty acid binding protein 4 inhibitor, promotes adipogenesis of 3T3-L1 cells by activating PPARγ.
Wang Y; Lin HQ; Law WK; Liang WC; Zhang JF; Hu JS; Ip TM; Waye MM; Wan DC
ACS Chem Neurosci; 2015 Feb; 6(2):211-8. PubMed ID: 25437245
[TBL] [Abstract][Full Text] [Related]
7. Piperine, a component of black pepper, inhibits adipogenesis by antagonizing PPARγ activity in 3T3-L1 cells.
Park UH; Jeong HS; Jo EY; Park T; Yoon SK; Kim EJ; Jeong JC; Um SJ
J Agric Food Chem; 2012 Apr; 60(15):3853-60. PubMed ID: 22463744
[TBL] [Abstract][Full Text] [Related]
8. Activation of adipogenesis by lipocalin-type prostaglandin D synthase-generated Δ¹²-PGJ₂ acting through PPARγ-dependent and independent pathways.
Fujimori K; Maruyama T; Kamauchi S; Urade Y
Gene; 2012 Aug; 505(1):46-52. PubMed ID: 22664386
[TBL] [Abstract][Full Text] [Related]
9. Regulatory effects of 4-methoxychalcone on adipocyte differentiation through PPARγ activation and reverse effect on TNF-α in 3T3-L1 cells.
Han Y; Lee SH; Lee IS; Lee KY
Food Chem Toxicol; 2017 Aug; 106(Pt A):17-24. PubMed ID: 28528971
[TBL] [Abstract][Full Text] [Related]
10. Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation.
Hu Y; Davies GE
Phytomedicine; 2009 Sep; 16(9):864-73. PubMed ID: 19403287
[TBL] [Abstract][Full Text] [Related]
11. Anti-adipogenic activity of a new cyclic diarylheptanoid isolated from Alnus japonica on 3T3-L1 cells via modulation of PPARγ, C/EBPα and SREBP1c signaling.
Sung SH; Lee M
Bioorg Med Chem Lett; 2015 Oct; 25(20):4648-51. PubMed ID: 26341132
[TBL] [Abstract][Full Text] [Related]
12. PPARγ neddylation essential for adipogenesis is a potential target for treating obesity.
Park HS; Ju UI; Park JW; Song JY; Shin DH; Lee KH; Jeong LS; Yu J; Lee HW; Cho JY; Kim SY; Kim SW; Kim JB; Park KS; Chun YS
Cell Death Differ; 2016 Aug; 23(8):1296-311. PubMed ID: 26990658
[TBL] [Abstract][Full Text] [Related]
13. A computational study to identify the key residues of peroxisome proliferator-activated receptor gamma in the interactions with its antagonists.
Sharifi T; Ghayeb Y
J Biomol Struct Dyn; 2018 May; 36(7):1822-1833. PubMed ID: 28566016
[TBL] [Abstract][Full Text] [Related]
14. Identification of the anti-fungal drug fenticonazole nitrate as a novel PPARγ-modulating ligand with good therapeutic index: Structure-based screening and biological validation.
Ma L; Lian Y; Tang J; Chen F; Gao H; Zhou Z; Hou N; Yi W
Pharmacol Res; 2021 Nov; 173():105860. PubMed ID: 34461220
[TBL] [Abstract][Full Text] [Related]
15. Identification of a New Type of Covalent PPARγ Agonist using a Ligand-Linking Strategy.
Ohtera A; Miyamae Y; Yoshida K; Maejima K; Akita T; Kakizuka A; Irie K; Masuda S; Kambe T; Nagao M
ACS Chem Biol; 2015 Dec; 10(12):2794-804. PubMed ID: 26414848
[TBL] [Abstract][Full Text] [Related]
16. Chebulagic acid from Terminalia chebula enhances insulin mediated glucose uptake in 3T3-L1 adipocytes via PPARγ signaling pathway.
Shyni GL; Kavitha S; Indu S; Arya AD; Anusree SS; Vineetha VP; Vandana S; Sundaresan A; Raghu KG
Biofactors; 2014; 40(6):646-57. PubMed ID: 25529897
[TBL] [Abstract][Full Text] [Related]
17. Extract of Chaga mushroom (Inonotus obliquus) stimulates 3T3-L1 adipocyte differentiation.
Joo JI; Kim DH; Yun JW
Phytother Res; 2010 Nov; 24(11):1592-9. PubMed ID: 21031614
[TBL] [Abstract][Full Text] [Related]
18. L312, a novel PPARγ ligand with potent anti-diabetic activity by selective regulation.
Xie X; Zhou X; Chen W; Long L; Li W; Yang X; Li S; Wang L
Biochim Biophys Acta; 2015 Jan; 1850(1):62-72. PubMed ID: 25305559
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the Stat5A/5B-PPARgamma pathway.
Kawai M; Namba N; Mushiake S; Etani Y; Nishimura R; Makishima M; Ozono K
J Mol Endocrinol; 2007 Feb; 38(1-2):19-34. PubMed ID: 17242167
[TBL] [Abstract][Full Text] [Related]
20. The dipeptide H-Trp-Glu-OH shows highly antagonistic activity against PPARgamma: bioassay with molecular modeling simulation.
Ye F; Zhang ZS; Luo HB; Shen JH; Chen KX; Shen X; Jiang HL
Chembiochem; 2006 Jan; 7(1):74-82. PubMed ID: 16317783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
